Downloads: 178

Files in This Item:
File Description SizeFormat 
25_0621.pdf667.07 kBAdobe PDFView/Open
Title: 前立腺肥大症におけるTSAA-291の治験成績--超音波計測による前立腺の縮小効果を中心として--
Other Titles: CLINICAL STUDIES ON TSAA-291 IN THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY: REDUCTION EFFECT ON THE PROSTATIC WEIGHT USING TRANSRECTAL ULTRASONOTOMOGRAPHY
Authors: 澤村, 良勝  KAKEN_name
三浦, 一陽  KAKEN_name
柳下, 次雄  KAKEN_name
田島, 政晴  KAKEN_name
安藤, 弘  KAKEN_name
Author's alias: Sawamura, Yoshikatsu
Miura, Kazukiyo
Yagishita, Tsuguo
Tajima, Masaharu
Ando, Ko
Issue Date: Jun-1979
Publisher: 京都大学医学部泌尿器科学教室
Journal title: 泌尿器科紀要
Volume: 25
Issue: 6
Start page: 621
End page: 626
Abstract: TSAA-291 was administered intramuscularly 400 mg (2 vials) a week for 13 weeks to 20 cases of advanced benign prostatic hypertrophy requiring operative treatments. In 2 cases (10%), a considerable reduction of the prostatic weight was noticed on measurement using transrectal ultrasonotomography. In other 8 cases (40%), reductive change was observed on the weight. Eight cases were closely followed up and no rebound effect was recognized after the completion of drug administration and reduced weight was kept. Relief of the symptoms or complaints was obtained in 17 cases (85%), and the decrease of nocturnal frequency in 14 cases (70%). Only one case needed an operative treatment after the completion of administration out of these 20 advanced cases. Clinical effectiveness was beyond our expectation.
URI: http://hdl.handle.net/2433/122444
Appears in Collections:Vol.25 No.6

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.